NEW YORK (GenomeWeb News) – Portuguese genetic testing company CGC Genetics has opened its US headquarters in Newark, NJ, and has established an affiliation agreement with the Institute of Genomic Medicine (IGM) at Newark's New Jersey Medical School.
The company held a ribbon-cutting for the facility with Newark Mayor Corey Booker and other representatives from city government last week.
CGC Genetics offers more than 1,500 genetic tests for prenatal screening, diagnostics, and pharmacogenetics in a range of areas including oncology and other common and rare diseases.
CGC and IGM share complementary genetic diagnostics technologies, the company said late last week, including "a broad menu of clinical tests that cover almost every genetic test available and a significant R&D infrastructure ensuring the rapid development and availability of new tests to CGC clients and partners."
CGC was wooed to New Jersey in part by efforts from the City of Newark and by Brick City Development Corporation, both of which traveled to Portugal three times in recent years and hosted Portuguese companies through a business attraction campaign.
"Our medical genetic business will benefit from Newark's convenient location, extensive infrastructure, and prestigious medical schools," CGC Genetics' CEO Purificação Tavares said in a statement.
CGC Genetics has facilities and offices in Oporto and Lisbon in Portugal, in Madrid, and in New York City.